|
Real-time Estimate
Cboe BZX
01:29:54 01/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 61.52 USD | +0.03% |
|
-6.61% | -3.95% |
| 27/08 | Dolby Laboratories, Inc. Announces Management Changes, Effective August 27, 2026 | CI |
| 27/08 | Dolby Laboratories, Inc. Announces CEO Changes, Effective August 27, 2026 | CI |
Company Valuation: Dolby Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 9,375 | 6,589 | 7,494 | 7,231 | 6,938 | 5,761 | - | - |
| Change | - | -29.72% | 13.74% | -3.51% | -4.05% | -16.97% | - | - |
| Enterprise Value (EV) | 8,103 | 5,772 | 7,494 | 7,231 | 6,938 | 5,761 | 5,761 | 5,761 |
| Change | - | -28.77% | 29.85% | -3.51% | -4.05% | -16.97% | 0% | 0% |
| P/E | 31.1x | 37.3x | 38.2x | 28.2x | 27.6x | 19.8x | 17.5x | 16.7x |
| PBR | 3.6x | 2.88x | - | - | 2.65x | 2.2x | - | - |
| PEG | - | -1x | 2.9x | 0.9x | -10.61x | 1.1x | 1.3x | 3.51x |
| Capitalization / Revenue | 7.32x | 5.26x | 5.77x | 5.68x | 5.14x | 4.06x | 3.93x | 3.75x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 4.06x | 3.93x | 3.75x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 10.5x | 10.1x | 9.27x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 19x | 17x | 14.2x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 13.9x | 11.7x | 10.7x |
| FCF Yield | 4.2% | 4.11% | 4.49% | 4.11% | 6.28% | 7.18% | 8.55% | 9.36% |
| Dividend per Share 2 | 0.91 | 1.02 | 1.11 | - | 1.32 | - | - | - |
| Rate of return | 0.98% | 1.51% | 1.42% | - | 1.82% | - | - | - |
| EPS 2 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 | 3.1 | 3.522 | 3.69 |
| Distribution rate | 30.6% | 56.4% | 54.1% | - | 50.4% | - | - | - |
| Net sales 1 | 1,281 | 1,254 | 1,300 | 1,274 | 1,349 | 1,420 | 1,467 | 1,535 |
| EBITDA 1 | 550.2 | 420.6 | 463.9 | 460.1 | 496.3 | 547.1 | 569.6 | 621.2 |
| EBIT 1 | 344.4 | 206.6 | 215.8 | 258.3 | 265 | 302.5 | 339.2 | 404.7 |
| Net income 1 | 310.2 | 184.1 | 200.7 | 261.8 | 255 | 255.7 | 292.3 | 349 |
| Net Debt | -1,272 | -817.6 | - | - | - | - | - | - |
| Reference price 2 | 92.47 | 67.46 | 78.36 | 75.84 | 72.39 | 61.50 | 61.50 | 61.50 |
| Nbr of stocks (in thousands) | 1,01,387 | 97,677 | 95,641 | 95,348 | 95,844 | 93,669 | - | - |
| Announcement Date | 16/11/21 | 17/11/22 | 16/11/23 | 19/11/24 | 18/11/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.84x | - | - | - | 576.06Cr | |
| -430.34x | 8.27x | 30.89x | -.--% | 2.98TCr | |
| -666.98x | 0.89x | 12.78x | -.--% | 538.41Cr | |
| 69.39x | 2.13x | 12.69x | -.--% | 425.74Cr | |
| -43.62x | 4.86x | 71.12x | - | 152.86Cr | |
| 22.25x | - | - | - | 45Cr | |
| 133.36x | 4.68x | 15.13x | - | 38Cr | |
| Average | -128.02x | 4.17x | 28.52x | 0% | 679.36Cr | |
| Weighted average by Cap. | -336.61x | 6.52x | 28.00x | 0% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DLB Stock
- Valuation Dolby Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
